Humana Inc

Chart & Performance

D1W1MN

No data to show

P/E

24.19

P/S

0.25

EPS

10.00

Div Yield, %

1.46%

Shrs. gr., 5y

-2.15%

Rev. gr., 5y

12.66%

Revenues

117.76b

+10.70%

Net income

1.21b

-51.51%

CFO

2.97b

-25.50%

Dividend

Jun 27, 20250.885 USD/sh

Earnings

Jul 29, 2025

Profile

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

URL

https://www.humana.com/

IPO date

May 18, 1971

Employees

67,100

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	117,761,000 10.70%	106,374,000 14.54%	92,870,000 11.81%
Cost of revenue		13,188,000	12,671,000
Unusual Expense (Income)
NOPBT	117,761,000	93,186,000	80,199,000
NOPBT Margin	100.00%	87.60%	86.36%
Operating Taxes	413,000	836,000	762,000
Tax Rate	0.35%	0.90%	0.95%
NOPAT	117,348,000	92,350,000	79,437,000
Net income	1,207,000 -51.51%	2,489,000 -11.30%	2,806,000 -4.33%
Dividends	(431,000)	(431,000)	(392,000)
Dividend yield	1.41%	0.76%	0.60%
Proceeds from repurchase of equity	(817,000)	(1,573,000)	(2,096,000)
BB yield	2.66%	2.76%	3.22%
Debt
Debt current	577,000	1,443,000	2,263,000
Long-term debt	11,144,000	10,657,000	9,490,000
Deferred revenue			286,000
Other long-term liabilities	1,951,000	1,662,000	(1,164,000)
Net debt	(9,135,000)	(10,342,000)	20,197,000
Cash flow
Cash from operating activities	2,966,000	3,981,000	4,587,000
CAPEX	(575,000)	(1,004,000)	(1,120,000)
Cash from investing activities	(2,952,000)	(3,492,000)	(1,006,000)
Cash from financing activities	(2,487,000)	(856,000)	(1,914,000)
FCF	118,356,000	82,692,000	79,507,000
Balance
Cash	20,435,000	21,320,000	5,061,000
Long term investments	421,000	1,122,000	(13,505,000)
Excess cash	14,967,950	17,123,300
Stockholders' equity	27,353,000	26,630,000	24,280,000
Invested Capital	15,149,050	12,512,700	27,262,000
ROIC	848.45%	464.37%	278.06%
ROCE	391.01%	314.44%	285.00%
EV
Common stock shares outstanding	120,869	124,441	127,094
Price	253.71 -44.58%	457.81 -10.62%	512.19 10.42%
Market cap	30,665,674 -46.17%	56,970,334 -12.48%	65,096,276 8.45%
EV	21,600,674	46,684,334	85,352,276
EBITDA	118,729,000	94,103,000	81,044,000
EV/EBITDA	0.18	0.50	1.05
Interest	660,000	493,000	401,000
Interest/NOPBT	0.56%	0.53%	0.50%